RecruitingPhase 4NCT06506565

Low-Dose Ketamine Infusion During Burn Wound Care

A Randomized, Placebo-Controlled, Double-Blind Evaluation of Low-Dose Ketamine Infusion During Burn Wound Care Procedures to Improve Pain Intensity and Reduce Opioid Consumption


Sponsor

University of Tennessee

Enrollment

140 participants

Start Date

Jul 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The current standard of care (SOC) (i.e. fentanyl and midazolam) offers limited efficacy for preventing or relieving pain. Ketamine infusions may provide the benefits of analgesia, minimize adverse events, and reduce opioid use. The purpose of this study is to determine if adding a low dose ketamine infusion during wound care will safely provide pain relief for patients with burn injury.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • Admitted to burn service with thermal injury

Exclusion Criteria7

  • unable/unwilling to consent within 72 hours
  • unable to report NRS
  • known contraindication to ketamine
  • < than 18 years of age
  • pregnant
  • incarcerated
  • TBSA over 50 %

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGKetamine

Infusion during wound care

DRUG0.9% NaCl

Infusion during wound care


Locations(1)

Regional One Health

Memphis, Tennessee, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06506565


Related Trials